{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:45:04Z","timestamp":1791564304753,"version":"4.3.4"},"reference-count":45,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Older patients using many prescription drugs (hyperpolypharmacy) may be at increased risk of adverse drug effects.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To test the effectiveness and safety of a quality intervention intended to reduce hyperpolypharmacy.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This randomized clinical trial allocated patients 76 years or older who used 10 or more prescription medications to a deprescribing intervention or to usual care (1:1 ratio) at an integrated health system with multiple preexisting deprescribing workflows. Data were collected from October 15, 2020, to July 29, 2022.<\/jats:p>\n <\/jats:sec>\n \n Intervention<\/jats:title>\n Physician-pharmacist collaborative drug therapy management, standard-of-care practice recommendations, shared decision-making, and deprescribing protocols administered by telephone over multiple cycles for a maximum of 180 days after allocation.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Primary end points were change in the number of medications and in the prevalence of geriatric syndrome (falls, cognition, urinary incontinence, and pain) from 181 to 365 days after allocation compared with before randomization. Secondary outcomes were use of medical services and adverse drug withdrawal effects.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Of a random sample of 2860 patients selected for potential enrollment, 2470 (86.4%) remained eligible after physician authorization, with 1237 randomized to the intervention and 1233 to usual care. A total of 1062 intervention patients (85.9%) were reached and agreed to enroll. Demographic variables were balanced. The median age of the 2470 patients was 80 (range, 76-104) years, and 1273 (51.5%) were women. In terms of race and ethnicity, 185 patients (7.5%) were African American, 234 (9.5%) were Asian or Pacific Islander, 220 (8.9%) were Hispanic, 1574 (63.7%) were White (63.7%), and 257 (10.4%) were of other (including American Indian or Alaska Native, Native Hawaiian, or &amp;gt;1 race or ethnicity) or unknown race or ethnicity. During follow-up, both the intervention and usual care groups had slight reductions in the number of medications dispensed (mean changes, \u22120.4 [95% CI, \u22120.6 to \u22120.2] and \u22120.4 [95% CI, \u22120.6 to \u22120.3], respectively), with no difference between the groups (\n P<\/jats:italic>\n \u2009=\u2009.71). There were no significant changes in the prevalence of a geriatric condition in the usual care and intervention groups at the end of follow-up and no difference between the groups (baseline prevalence: 47.7% [95% CI, 44.9%-50.5%] vs 42.9% [95% CI, 40.1%-45.7%], respectively; difference-in-differences, 1.0 [95% CI, \u22123.5 to 5.6];\n P<\/jats:italic>\n \u2009=\u2009.65). No differences in use of medical services or adverse drug withdrawal effects were observed.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this randomized clinical trial from an integrated care setting with various preexisting deprescribing workflows, a bundled hyperpolypharmacy deprescribing intervention was not associated with reduction in medication dispensing, prevalence of geriatric syndrome, utilization of medical services, or adverse drug withdrawal effects. Additional research is needed in less integrated settings and in more targeted populations.<\/jats:p>\n <\/jats:sec>\n \n Trial Registration<\/jats:title>\n \n ClinicalTrials.gov Identifier:\n NCT05616689<\/jats:ext-link>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.22505","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T11:12:34Z","timestamp":1688987554000},"page":"e2322505","source":"Crossref","is-referenced-by-count":23,"title":["Effectiveness of Bundled Hyperpolypharmacy Deprescribing Compared With Usual Care Among Older Adults"],"prefix":"10.1001","volume":"6","author":[{"given":"Lisa J.","family":"Herrinton","sequence":"first","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keras","family":"Lo","sequence":"additional","affiliation":[{"name":"Pharmacy Operations, Kaiser Permanente Northern California, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mubarika","family":"Alavi","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey E.","family":"Alexeeff","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerri M.","family":"Butler","sequence":"additional","affiliation":[{"name":"Pharmacy Operations, Kaiser Permanente Northern California, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carter","family":"Chang","sequence":"additional","affiliation":[{"name":"Adult and Family Medicine, Kaiser Permanente Northern California, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Chang","sequence":"additional","affiliation":[{"name":"Pharmacy Operations, Kaiser Permanente Northern California, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia L.","family":"Chu","sequence":"additional","affiliation":[{"name":"Pharmacy Operations, Kaiser Permanente Northern California, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Krishnaswami","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kaiser Permanente Northern California, San Jose"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn H.","family":"Deguzman","sequence":"additional","affiliation":[{"name":"Pharmacy Operations, Kaiser Permanente Northern California, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Prausnitz","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Mason","sequence":"additional","affiliation":[{"name":"Geriatrics and Continuing Care, Kaiser Permanente Northern California, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maisha","family":"Draves","sequence":"additional","affiliation":[{"name":"Adult and Family Medicine, Kaiser Permanente Northern California, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,7,10]]},"reference":[{"issue":"3","key":"zoi230665r1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-020270","article-title":"Factors associated with polypharmacy in primary care: a cross-sectional analysis of data from the English Longitudinal Study of Ageing (ELSA).","volume":"8","author":"Slater","year":"2018","journal-title":"BMJ Open"},{"key":"zoi230665r2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2019.05.010","article-title":"Medication taking in a national sample of dependent older people.","author":"Ferguson","journal-title":"Res Social Adm Pharm"},{"issue":"5","key":"zoi230665r3","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/jgs.2019.67.issue-5","article-title":"Assessing the scope and appropriateness of prescribing cascades.","volume":"67","author":"McCarthy","year":"2019","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"zoi230665r4","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/bcp.12732","article-title":"A systematic review of the emerging definition of \u201cdeprescribing\u201d with network analysis: implications for future research and clinical practice.","volume":"80","author":"Reeve","year":"2015","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"zoi230665r5","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/bcp.v82.3","article-title":"The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis.","volume":"82","author":"Page","year":"2016","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"zoi230665r6","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1111\/jgs.v70.9","article-title":"Recommendations for outcome measurement for deprescribing intervention studies.","volume":"70","author":"Bayliss","year":"2022","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"zoi230665r7","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jamda.2018.06.021","article-title":"Deprescribing medications for chronic diseases management in primary care settings: a systematic review of randomized controlled trials.","volume":"19","author":"Dills","year":"2018","journal-title":"J Am Med Dir Assoc"},{"issue":"2","key":"zoi230665r9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/2042098611400332","article-title":"A pilot randomized controlled trial of deprescribing.","volume":"2","author":"Beer","year":"2011","journal-title":"Ther Adv Drug Saf"},{"issue":"4","key":"zoi230665r10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s40266-014-0157-5","article-title":"Reduction of potentially inappropriate medications using the STOPP criteria in frail older inpatients: a randomised controlled study.","volume":"31","author":"Dalleur","year":"2014","journal-title":"Drugs Aging"},{"issue":"4","key":"zoi230665r11","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S0002-9343(97)89519-8","article-title":"A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy.","volume":"100","author":"Hanlon","year":"1996","journal-title":"Am J Med"},{"issue":"3","key":"zoi230665r12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149984","article-title":"Deprescribing in frail older people: a randomised controlled trial.","volume":"11","author":"Potter","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"zoi230665r13","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1001\/jamainternmed.2022.0502","article-title":"Deprescribing education vs usual care for patients with cognitive impairment and primary care clinicians: the OPTIMIZE pragmatic cluster randomized trial.","volume":"182","author":"Bayliss","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"1","key":"zoi230665r14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/fampra\/cmw073","article-title":"Randomized controlled trial of an intervention to improve drug appropriateness in community-dwelling polymedicated elderly people.","volume":"34","author":"Campins","year":"2017","journal-title":"Fam Pract"},{"issue":"10","key":"zoi230665r15","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1111\/jgs.15042","article-title":"Effect of the tool to reduce inappropriate medications on medication communication and deprescribing.","volume":"65","author":"Fried","year":"2017","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"zoi230665r16","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3109\/02813432.2014.972062","article-title":"Effects of a pharmacist-led structured medication review in primary care on drug-related problems and hospital admission rates: a randomized controlled trial.","volume":"32","author":"Lenander","year":"2014","journal-title":"Scand J Prim Health Care"},{"issue":"4","key":"zoi230665r17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s40266-013-0057-0","article-title":"Improving the quality of pharmacotherapy in elderly primary care patients through medication reviews: a randomised controlled study.","volume":"30","author":"Milos","year":"2013","journal-title":"Drugs Aging"},{"issue":"2","key":"zoi230665r18","doi-asserted-by":"publisher","first-page":"173","DOI":"10.18553\/jmcp.2018.24.2.173","article-title":"Prevalence and management of drug-related problems in chronic kidney disease patients by severity level: a subanalysis of a cluster randomized controlled trial in community pharmacies.","volume":"24","author":"Quintana-B\u00e1rcena","year":"2018","journal-title":"J Manag Care Spec Pharm"},{"key":"zoi230665r19","doi-asserted-by":"publisher","first-page":"m1822","DOI":"10.1136\/bmj.m1822","article-title":"Use of an electronic decision support tool to reduce polypharmacy in elderly people with chronic diseases: cluster randomised controlled trial.","volume":"369","author":"Rieckert","year":"2020","journal-title":"BMJ"},{"issue":"3","key":"zoi230665r20","doi-asserted-by":"publisher","DOI":"10.3399\/bjgpopen20X101096","article-title":"Barriers and facilitators to deprescribing in primary care: a systematic review.","volume":"4","author":"Doherty","year":"2020","journal-title":"BJGP Open"},{"issue":"4","key":"zoi230665r21","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/jgs.12226","article-title":"American Geriatrics Society identifies five things that healthcare providers and patients should question.","volume":"61","author":"AGS Choosing Wisely Workgroup","year":"2013","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"zoi230665r24","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/imj.12693","article-title":"Physicians need to take the lead in deprescribing.","volume":"45","author":"Scott","year":"2015","journal-title":"Intern Med J"},{"key":"zoi230665r25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2016.12.021","article-title":"Deprescribing: a narrative review of the evidence and practical recommendations for recognizing opportunities and taking action.","volume":"38","author":"Reeve","year":"2017","journal-title":"Eur J Intern Med"},{"issue":"18","key":"zoi230665r26","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1503\/cmaj.131873","article-title":"Deprescribing for older patients.","volume":"186","author":"Frank","year":"2014","journal-title":"CMAJ"},{"issue":"1","key":"zoi230665r27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1136\/ejhpharm-2015-000864","article-title":"Review of structured guides for deprescribing.","volume":"24","author":"Scott","year":"2017","journal-title":"Eur J Hosp Pharm"},{"issue":"5","key":"zoi230665r28","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","article-title":"Reducing inappropriate polypharmacy: the process of deprescribing.","volume":"175","author":"Scott","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"2","key":"zoi230665r31","doi-asserted-by":"publisher","first-page":"217","DOI":"10.31887\/DCNS.2011.13.2\/npatsopoulos","article-title":"A pragmatic view on pragmatic trials.","volume":"13","author":"Patsopoulos","year":"2011","journal-title":"Dialogues Clin Neurosci"},{"issue":"5","key":"zoi230665r32","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1111\/(ISSN)1532-5415","article-title":"Geriatric syndromes: clinical, research, and policy implications of a core geriatric concept.","volume":"55","author":"Inouye","year":"2007","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"zoi230665r33","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12913-019-3995-3","article-title":"A patient-centered deprescribing intervention for hospitalized older patients with polypharmacy: rationale and design of the Shed-MEDS randomized controlled trial.","volume":"19","author":"Vasilevskis","year":"2019","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"zoi230665r37","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2307\/2530245","article-title":"A multiple testing procedure for clinical trials.","volume":"35","author":"O\u2019Brien","year":"1979","journal-title":"Biometrics"},{"issue":"4","key":"zoi230665r38","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1007\/s11096-016-0281-x","article-title":"Implications of a clinical medication review and a pharmaceutical care plan of polypharmacy patients with a cardiovascular disorder.","volume":"38","author":"Geurts","year":"2016","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"zoi230665r39","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1186\/s12877-021-02612-0","article-title":"Expert-based medication reviews to reduce polypharmacy in older patients in primary care: a northern-Italian cluster-randomised controlled trial.","volume":"21","author":"Mahlknecht","year":"2021","journal-title":"BMC Geriatr"},{"issue":"1","key":"zoi230665r40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003862","article-title":"GP-delivered medication review of polypharmacy, deprescribing, and patient priorities in older people with multimorbidity in Irish primary care (SPPiRE Study): a cluster randomised controlled trial.","volume":"19","author":"McCarthy","year":"2022","journal-title":"PLoS Med"},{"issue":"7","key":"zoi230665r41","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-019042","article-title":"Reducing the anticholinergic and sedative load in older patients on polypharmacy by pharmacist-led medication review: a randomised controlled trial.","volume":"8","author":"van der Meer","year":"2018","journal-title":"BMJ Open"},{"issue":"1","key":"zoi230665r42","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1186\/s12877-020-01870-8","article-title":"Effect of a patient-centred deprescribing procedure in older multimorbid patients in Swiss primary care\u2014a cluster-randomised clinical trial.","volume":"20","author":"Zechmann","year":"2020","journal-title":"BMC Geriatr"},{"issue":"2","key":"zoi230665r43","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1001\/jamainternmed.2019.5096","article-title":"Effect of clinical geriatric assessments and collaborative medication reviews by geriatrician and family physician for improving health-related quality of life in home-dwelling older patients receiving polypharmacy: a cluster randomized clinical trial.","volume":"180","author":"Romskaug","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"1","key":"zoi230665r44","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.amjmed.2018.09.030","article-title":"Impact of geriatrician-performed comprehensive geriatric care on medication use and cognitive function in older adults referred to a non\u2013hospital-based rehabilitation unit.","volume":"132","author":"Zintchouk","year":"2019","journal-title":"Am J Med"},{"issue":"11","key":"zoi230665r45","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1007\/s11606-020-06089-2","article-title":"Deprescribing for community-dwelling older adults: a systematic review and meta-analysis.","volume":"35","author":"Bloomfield","year":"2020","journal-title":"J Gen Intern Med"},{"key":"zoi230665r8","first-page":"1291","article-title":"Efficacy of a clinical medication review on the number of potentially inappropriate prescriptions prescribed for community-dwelling elderly people.","volume-title":"CMAJ","author":"Allard","year":"2001"},{"key":"zoi230665r34","doi-asserted-by":"crossref","DOI":"10.1002\/9781119512684","volume-title":"Data Monitoring Committees in Clinical Trials: A Practical Perspective","author":"Ellenberg","year":"2019","edition":"2nd ed"},{"key":"zoi230665r22","unstructured":"Office for Human Research Protections, US Department of Health and Human Services. Quality improvement activities FAQs: if I plan to carry out a quality improvement project and publish the results, does the intent to publish make my quality improvement project fit the regulatory definition of research? Revised October 13, 2022. Accessed May 11, 2023. https:\/\/www.hhs.gov\/ohrp\/regulations-and-policy\/guidance\/faq\/quality-improvement-activities\/index.html"},{"key":"zoi230665r23","unstructured":"Agency for Healthcare Research and Quality. The SHARE approach. Reviewed March 2023. Accessed June 6, 2023. https:\/\/www.ahrq.gov\/health-literacy\/professional-training\/shared-decision\/index.html"},{"key":"zoi230665r29","unstructured":"Pharmacy Quality Alliance. PQA Medication Therapy Problem Categories Framework. Updated March 5, 2021. Accessed October 25, 2021. https:\/\/www.pqaalliance.org\/pqa-measures"},{"key":"zoi230665r30","unstructured":"Academy of Managed Care Pharmacy. Practice advisory on collaborative drug therapy management. February 2012. Accessed August 31, 2021. https:\/\/www.amcp.org\/sites\/default\/files\/2019-03\/Practice%20Advisory%20on%20CDTM%202.2012_0.pdf"},{"key":"zoi230665r35","unstructured":"Warton? EM, Parker? MM. Oops, I D-I-D it again! advanced difference-in-differences models in SAS. Paper 25-2018. Accessed September 13, 2022. https:\/\/www.lexjansen.com\/wuss\/2018\/25_Final_Paper_PDF.pdf"},{"key":"zoi230665r36","unstructured":"Warton? EM, Parker? MM, Karter? AJ. How D-I-D you do that? basic difference-indifference models in SAS. September 5-7, 2016. Accessed September 13, 2022. https:\/\/www.lexjansen.com\/wuss\/2016\/49_Final_Paper_PDF.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2807112\/herrinton_2023_oi_230665_1688131477.01016.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T11:12:41Z","timestamp":1688987561000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2807112"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2023,7,10]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.22505","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,10]]}}}